The targeting of inositol 1,4,5-triphosphate-3-kinase B (ITPKB) leads to a significant increase in miR-375 expression in SCLC, resulting in enhanced cell growth and reduced ITPKB protein levels [45]. This evidence concerns the gene ITPKB and small cell lung carcinoma.